Cancer Therapy News and Research

RSS

Some insurers refusing to pay for proton-beam cancer therapy

Blue Shield of California joins two other insurers who contend that other cancer treatments are just as good, and far less expensive.

30 Aug 2013

First Edition: August 29, 2013

Today's headlines include reports about ongoing fiscal fights surrounding efforts to raise the nation's debt limit and to defund the health law. Also, the White House enlists former President Bill Clinton to help spread the word about the overhaul.

29 Aug 2013

Many men find prostate cancer treatment as a big challenge

After fighting off prostate cancer and beginning the road to recovery, many men are finding the expense of cancer treatment is almost as big a challenge as the disease.

29 Aug 2013

Jia Shen receives 2013 Jess Hay Chancellor's Graduate Student Research Fellowship

Jia Shen, a student at The University of Texas Graduate School of Biomedical Sciences at Houston, is a recipient of a 2013 Jess Hay Chancellor's Graduate Student Research Fellowship. This award is given to two students per year across the entire University of Texas System, which is comprised of nine universities and six health institutions.

29 Aug 2013

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Women undergoing treatment for breast cancer are widely prescribed calcium and vitamin D supplements to prevent and manage osteoporosis, an unwanted side effect of breast cancer therapies.

28 Aug 2013

Novel Parkinson’S Target Uncovered

Researchers from Johns Hopkins and the National Cancer Institute (NCI) highlighted a novel mechanism underlying Parkinson's disease while simultaneously putting to rest a previously held theory regarding progression of the disorder. They also identified a compound that alleviates the disease's symptoms in mice.

27 Aug 2013

Viewpoints: 'Mixed signals' on employee benefits; Michigan debates Medicaid expansion; malpractice awards drive safety

It is hard to know whether to rejoice or lament two striking if somewhat conflicting messages last week about the costs of employer-sponsored health insurance. An authoritative survey found that premiums for family and individual coverage at work - including both the company's and the worker's share - have gone up only moderately for the second year in a row.

27 Aug 2013

New bioinformatics software tool to identify genetic mutations responsible for cancers

Researchers at the Medical College of Wisconsin (MCW) have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers. The tool, called DrGaP, is the subject of a new paper published in the American Journal of Human Genetics.

27 Aug 2013

Researchers identify compound that eases symptoms of Parkinson's disease

Researchers at Johns Hopkins and elsewhere have brought new clarity to the picture of what goes awry in the brain during Parkinson's disease and identified a compound that eases the disease's symptoms in mice.

26 Aug 2013

Seven researchers to receive grants from ASTRO to advance radiation oncology research

The American Society for Radiation Oncology (ASTRO) has selected seven (7) leading researchers who will receive a total of $675,000 in awards and grants to advance radiation oncology research.

23 Aug 2013

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

The U.S. Food and Drug Administration today allowed marketing in the U.S. of the first mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans.

22 Aug 2013

Research suggests restricting calories may improve success of cancer treatment

New research suggests that restricting calories for a defined period of time may improve the success of cancer treatment, offering valuable new data on how caloric intake may play a role in programmed cancer cell death and efficacy of targeted cancer therapies. Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH).

22 Aug 2013

Researchers find new strategy that has potential to change standard of care for DLBCL patients

Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commercially-available drug that made chemotherapy more effective.

20 Aug 2013

Phase III trial evaluates impact of Wisconsin Ginseng on fatigue levels of cancer patients

Millions of cancer patients find themselves exhausted completing the most mundane of tasks, and extra sleep doesn't seem to help. Today, they find hope in a supplement that medical researchers have shown to be effective in boosting their energy levels: Wisconsin Ginseng.

20 Aug 2013

New data analyzing technique via MR imaging identify tumors' response to anti-angiogenesis therapy

A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective.

20 Aug 2013

Pilot project designed to help patients navigate complex cancer treatment improves health care

An experimental health information exchange being tested in the north Georgia city of Rome is helping Koren Sinnock keep her travel plans. A breast cancer patient, Sinnock had been reluctant to travel very far from her doctors until the new program promised to provide access to her medical records from anywhere she might happen to be - including the beach.

20 Aug 2013

New type of cancer immunotherapy harnesses body's immune system to attack tumors

By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses.

19 Aug 2013

Powerful mechanism helps viruses evade body's immune response

Researchers at the Salk Institute for Biological Studies have discovered a powerful mechanism by which viruses such as influenza, West Nile and Dengue evade the body's immune response and infect humans with these potentially deadly diseases. The findings may provide scientists with an attractive target for novel antiviral therapies.

19 Aug 2013

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, announced today the publication of preclinical data on ATSP-7041, a potent and selective stapled peptide re-activator of the wild type p53 tumor suppressor protein.

17 Aug 2013

Sugar offers noninvasive way to precisely image tumors through new imaging technology

A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration with GE Healthcare.

16 Aug 2013

Cancer Therapy News and Research

Some insurers refusing to pay for proton-beam cancer therapy

First Edition: August 29, 2013

Many men find prostate cancer treatment as a big challenge

Jia Shen receives 2013 Jess Hay Chancellor's Graduate Student Research Fellowship

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Novel Parkinson’S Target Uncovered

Viewpoints: 'Mixed signals' on employee benefits; Michigan debates Medicaid expansion; malpractice awards drive safety

New bioinformatics software tool to identify genetic mutations responsible for cancers

Researchers identify compound that eases symptoms of Parkinson's disease

Seven researchers to receive grants from ASTRO to advance radiation oncology research

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

Research suggests restricting calories may improve success of cancer treatment

Researchers find new strategy that has potential to change standard of care for DLBCL patients

Phase III trial evaluates impact of Wisconsin Ginseng on fatigue levels of cancer patients

New data analyzing technique via MR imaging identify tumors' response to anti-angiogenesis therapy

Pilot project designed to help patients navigate complex cancer treatment improves health care

New type of cancer immunotherapy harnesses body's immune system to attack tumors

Powerful mechanism helps viruses evade body's immune response

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

Sugar offers noninvasive way to precisely image tumors through new imaging technology

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News